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Introduction
The membrane phospholipid phosphatidylinositol is the
precursor for a family of lipid second-messengers, known
collectively as phosphoinositides, that differ solely in the
phosphorylation status of their inositol head group
(Figure 1) [1,2]. Phosphoinositides are ideally suited to
function as spatially restricted membrane second messen-
gers because: the synthesis and turnover of phosphoinosi-
tides from the relatively abundant phosphatidylinositol
membrane precursor can be rapid and highly concentrated
within discrete membrane micro domains; the ratio of
phosphoinositide to binding partner can be relatively large,
which makes it possible to target a large number of distinct
proteins to a particular membrane without saturating the
binding sites; structurally distinct phosphoinositides can
activate distinct downstream effectors; and the potential for
rapid, sequential interconversion between phosphorylated
forms means that phosphoinositides can confer processivity
to membrane signalling events.
A major advance in our understanding of phosphoinositide
signalling has been the identification of a number of highly
conserved modular protein domains that bind various phos-
phoinositides. To date, a number of distinct, phosphoinosi-
tide-binding motifs have been identified and characterised
including the epsin amino-terminal homology (ENTH)
domain, Fab1, YOTB, Vac1 and EEA1 (FYVE) domain,
band 4.1, ezrin, radixin and moesin (FERM) domain, pleck-
strin homology (PH) domain and more recently the phox
homology (PX) domain [3]. Such ‘cut and paste’ modules
are found in a diverse array of multidomain proteins and
recruit their host protein to specific regions in cells via
their interactions with phosphoinositides. They may also
serve as allosteric regulators of enzyme activity and
protein–protein interactions. 
The binding of phosphoinositides to these domains is gen-
erally of low affinity and rapidly reversible which favors a
highly plastic system. These features enable signalling pro-
teins involved in phosphoinositide-mediated membrane
association to undergo a sequence of random diffusions in
the cytosol, interspersed with membrane binding and dis-
sociation events [4], rather than to associate persistently
with the membrane. Thus these signalling proteins are
constantly sampling a large area of the membrane environ-
ment for the presence of a phosphoinositide-binding
partner and any elevations in the mass of the partner lipid
results in a local enrichment or translocation of the sig-
nalling protein. As specific signalling phosphoinositides can
be readily produced and degraded by enzymatic activities,
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lifetimes of phosphoinositide-binding partner complexes
can be in the order of seconds to minutes. 
Phosphoinositide-binding proteins are therefore a restless
subclass of signalling proteins that spend a significant pro-
portion of their time diffusing through the cytosol, ready
to interact with their cognate phosphoinositide-binding
partner if and when they meet it. Here, with particular ref-
erence to proteins involved in membrane traffic pathways,
we discuss recent advances in our understanding of phos-
phoinositide-binding domains.
Pleckstrin homology domains
The recent first draft of the human genome sequence
showed that PH domains are the eleventh most common
domain in humans, appearing some 252 times in the
deduced human proteome. PH domains are small β-sand-
wich protein modules of approximately 120 residues that
occur once or, more rarely, several times in a protein
sequence (reviewed in [5]; see Figure 2). Nearly all PH
domain-containing proteins require membrane association
for some aspect of their function and most if not all PH
domains bind to phosphoinositides present in cell mem-
branes although with different degrees of specificity and
affinity. In 15–20% of cases phosphoinositide binding is
strong and highly specific. Studies using green fluorescent
protein (GFP) fusions have shown that phosphoinositide-
binding by PH domains is sufficient for their independent,
signal regulated targeting to cell membranes [3,6].
One of the first examples of such dynamic membrane tar-
geting was described for the ARF6 exchange factor ARNO
[7]. This cytosolic protein undergoes a rapid recruitment to
the plasma membrane (t½ approximately 30 seconds), fol-
lowing agonist activation of PI 3-kinase, via the specific
interaction of its PH domain with the lipid product of PI 3-
kinase activation, phosphatidylinositol 3,4,5-trisphosphate
(PIP3) (Figure 3). In contrast the PH domain of phospholi-
pase Cδ1 (PLCδ1), which specifically binds phosphatidyli-
nositol 4,5-bisphosphate (PI(4,5)P2), constitutively targets
this protein to the plasma membrane — an interaction that
regulates the activity of the enzyme [8].
The ability of certain PH domains to interact specifically
with a given phosphoinositide has recently been used to
gain invaluable insight into the spatial and temporal organi-
sation of phosphoinositide signalling events. Using the dis-
covery that GFP and its variants can be used as expressed
fluorescence tags to follow the subcellular localisation of
signalling proteins in live cells, a number of groups have
Figure 1
Phosphoinositide metabolism.
Phosphatidylinositol (PI), the basic building
block for the intracellular inositol lipids in
eukaryotic cells, consists of D-myo-inositol-1-
phosphate liked via its phosphate group to
almost exclusively 1-stearoyl, 2-arachidonoyl
diacylglycerol – a fatty acyl composition that
may contribute to an adequate packing of the
phosphoinositides leading to efficient exposure
of their inositol head group for interaction with
cytosolic proteins. Unlike the head groups of
other phospholipids, the inositol ring of
phosphatidylinositol can be reversibly
phosphorylated at one or a combination of the
3′, 4′ or 5′ positions. Phosphatidylinositol and
its phosphorylated derivatives are collectively
referred to as phosphoinositides.
Phosphatidylinositol is the most abundant
inositol lipid in mammalian cells under basal
conditions, present at levels 10–20 times
higher that those of phosphatidylinositol
4-monophosphate (PI(4)P) and
phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2), which are present in roughly equal
amounts. Of the total singly phosphorylated
phosphoinositides in cells, 90–96% is PI(4)P;
phosphatidylinositol 3-monophosphate (PI(3)P)
and phosphatidylinositol 5-monophosphate
(PI(5)P) each make up about 2–5%. PI(4,5)P2
is the most abundant of the doubly
phosphorylated phosphatidylinositols (>99%);
phosphatidylinositol 3,4-bisphosphate
(PI(3,4)P2) and phosphatidylinositol
3,5-bisphosphate (PI(3,5)P2) each make up
about 0.2% of the PIP2. The levels of
phosphatidylinositol 3,4,5-trisphosphate
(PI(3,4,5)P3) vary enormously but can be
comparable to those of PI(3,4)P2 and
PI(3,5)P2.
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tagged various PH domains to analyse stimulus-induced
changes in specific phosphoinositides [6]. For example, a
GFP conjugated PH domain from PLCδ1 has been used as
a detector for PI(4,5)P2 [8–16] whereas a corresponding
GFP conjugated PH domain, found in ARNO and other
specific PIP3-binding PH domains, functions as a biosensor
for PIP3 [7,17–21]. The recent availability of these reagents,
and similar tools based on other phosphoinositide-binding
modules (see below), has allowed researchers to study phos-
phoinositide signalling in living cells. These studies have
illustrated the highly dynamic and localised nature of phos-
phoinositide signalling.
Phosphatidylinositol 4,5-bisphosphate: a
localised regulator of membrane events?
Using the PI(4,5)P2 biosensor a number of recent studies
have shown that PI(4,5)P2 is mainly concentrated in the
plasma membrane, with dynamic changes in its levels
occurring at active sites of phagocytosis [12], actin-rich
protrusions and membrane ruffles [13]. These observa-
tions, together with data from biochemical and immunocy-
tochemical assays showing the presence of discontinuous,
raft-like clustering of PI(4,5)P2, support the idea that this
lipid is not uniformly distributed on the inner leaflet of the
plasma membrane but rather that it exists in gradients and
regionally localised areas of the plasma membrane [22].
Such dynamic and highly localised elevation of PI(4,5)P2
may result from the selective recruitment or activation of
specific phosphoinositide kinases increasing de novo syn-
thesis of PI(4,5)P2. Alternatively, under resting conditions
the pool of free PI(4,5)P2 may be effectively sequestered
by high affinity interactions with basic proteins or basic
domains of specific proteins [23].
Inhibition of these interactions would provide a potential
mechanism for rapidly releasing a local pool of PI(4,5)P2
for interactions with other proteins. Such a strategy would
not require the targeting or activation of phosphoinositide
kinases, but would require the local regulation of the inter-
action between PI(4,5)P2 and its tethering proteins [23].
Although our knowledge of the in vivo regulation of
enzymes that regulate PI(4,5)P2 synthesis is far from com-
plete, recent results have begun to shed some light on
these issues.
It appears that animal cells use two different routes of
PI(4,5)P2 synthesis (see Figure 1). One pathway, the ‘clas-
sical PI cycle’, involves the sequential phosphorylation of
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Figure 2
Structure of phosphoinoisitide-binding
modular domains. In the last year we have
witnessed a dramatic increase in our
appreciation of how specific modular binding
domains have evolved to recognise their
cognate phosphoinositide ligand. Depicted
here are the backbone structures for (a) the
PIP3-binding PH domain from Grp1 in
complex with inositol 1,3,4,5-
tetrakisphosphate [99,100], (b) the PI(3)P-
binding FYVE domain from EEA1 bound to
inositol 1,3-bisphosphate [65], (c) the PI(3)P-
binding PX domain from p47phox showing the
predicted PI(3)P-binding sites as determined
by NMR [75,101], (d) the PIP2-binding
domain from the clathrin assembly lymphoid
myeloid leukemia protein (CALM) in complex
with inositol 4,5-bisphosphate [33] and finally,
(e) the PIP2-binding FERM domain from
radixin in complex with inositol 1,4,5-
trisphosphate [102]. From comparing all of
these structures it is immediately apparent
that the structure of the phosphoinositide-
binding site is not conserved between
different types of phosphoinoisitide-binding
domain (see also the recently solved crystal
structure of the PX domain from p40phox
bound to PI(3)P [103]).
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phosphatidylinositol to phosphatidylinositol 4-monophos-
phate (PI(4)P) and PI(4,5)P2 [1,2]. In the second pathway,
only recently revealed, PI(4,5)P2 is synthesised from phos-
phatidylinositol via the novel lipid phosphat-idylinositol 5-
monophosphate (PI(5)P) [24]. The second step in each
pathway is catalysed by homologous lipid kinases, termed
type I and type II PIP kinases (Figure 1). Hence, type I
PIP kinases phosphorylate PI(4)P to PI(4,5)P2 and are
PI(4)P 5-kinases [24–26], whereas type II PIP kinases gen-
erate PI(4,5)P2 by phosphorylation of PI(5)P and are con-
sequently PI(5)P 4-kinases [24,26]. 
Although type I and II PIP kinases share significant
sequence identity they are not functionally redundant and
mainly localise to distinct subcellular compartments. In
mammalian cells, type I PIP kinases are found at the
plasma membrane where they have been implicated in the
regulation of actin rearrangements, secretion, and endocy-
tosis [26]. In contrast, type II PIP kinases are principally
localised to the cytosol, nucleus, endoplasmic reticulum,
and the actin cytoskeleton [26]. 
The type I PIP kinase PI(4)P 5-kinase α is a highly regu-
lated enzyme both allosterically and through membrane
targeting. It has been shown that PI(4)P 5-kinase α is acti-
vated by the GTP-bound form of the small GTPases Rac,
Rho and ARF6 as well as the product of phospholipase D
activation, phosphatidic acid [27]. The regulation of
PI(4)P 5-kinase α by both phosphatidic acid and
ARF6–GTP suggests a potential mechanism for an explo-
sive feed-forward regulatory loop for the acute, localised
synthesis of PI(4,5)P2. Given that PI(4,5)P2 and activated
ARF6 act synergistically to increase the activity of phos-
pholipase D, an elevation in active ARF6 would induce an
acute increase in phosphatidic acid which would itself
stimulate PI(4)P 5-kinase α to produce more PI(4,5)P2. 
The feed-forward aspect of this loop stems from the ability
of PI(4,5)P2 to activate certain ARF6 exchange factors
thereby increasing the GTP loading on ARF6, stimulating
PI(4)P 5-kinase α, to produce more PI(4,5)P2. Such a
mechanism is further supported by the demonstration that
ARF6, phospholipase D and PI(4)P 5-kinase α are recruited
to active sites of phagosome formation and sites of cyto-
skeleton assembly at membrane ruffles [12,13,27–31];
these regions are rich in PI(4,5)P2. Thus, mutual interac-
tions between PI(4,5)P2 and the proteins that regulate its
synthesis probably result in a highly cooperative and
dynamic regulation of PI(4,5)P2 synthesis in restricted
membrane domains. 
Phosphatidylinositol 4,5-bisphosphate as a
signal for membrane internalisation events
The concept of PI(4,5)P2 as a spatially localised regulator
of membrane events is clearly illustrated by its key role in
clathrin-mediated endocytosis. This complex mechanical
process is driven by the sequential action of a host of cellu-
lar proteins, many of which are recruited to the endocytic
site through PI(4,5)P2-binding modules [32]. Endocytosis
can be broken down into four distinct steps, the first being
the recruitment of clathrin to the endocytic site. This
process can be reconstituted in vitro by combining purified
clathrin, PI(4,5)P2-containing liposomes and just one
cofactor, the AP180 protein [33,34]. AP180 (and the
related protein CALM) binds directly to clathrin but also
contains a copy of the epsin amino-terminal homology
(ENTH) domain [35]. The ENTH domain is a phospho-
inositide-binding module that has recently been shown to
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Figure 3
Temporal dynamics of the epidermal growth
factor-induced plasma membrane association
of the PIP3-binding protein ARNO. Time-lapse
confocal imaging was performed on PC12 cells
transiently transfected with a construct
expressing GFP-tagged ARNO. 24 h after
transfection cells were serum-starved for 2 h
prior to imaging of a selected cell using an
UltraView confocal microscope. Images were
collected every 250 ms (for clarity only selected
images are shown). Epidermal growth factor
(100 ng/ml) was added immediately after
collection of the 20.7 s image. Culturing and
manipulation of transfected cells were as
described in [7]. The complete series of images
are presented as a time-lapse movie that can
be seen online at http://images.cellpress.com/
supmat/supmatin.htm.
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confer specific PI(4,5)P2 binding to a number of proteins
involved in endocytosis [32,36] (Figure 2). This fundamen-
tal observation is important as it suggests that PI(4,5)P2
may act as a site selection signal for endocytic events.
As yet there is no direct evidence for localised concentra-
tions of PI(4,5)P2 at sites of endocytosis, however agents
that disrupt lipid rafts have been shown to block clathrin-
mediated endocytosis [37,38], suggesting that structured
micro domains may be acting as endocytic seed sites. In
this respect it is interesting to note that type IIα PI
4-kinase has been shown to localise to lipid rafts through a
palmitoylation modification [39,40], suggesting, at least,
that concentrations of the precursor of PI(4,5)P2 exist in
the plasma membrane. One prediction of this hypothesis is
that site-directed mutagenesis of the palmitoylation site in
type IIα PI 4-kinase would disrupt endocytosis. 
Another important question is whether PI(4,5)P2 acts solely
as a passive marker for the entry site [41] or whether levels
of PI(4,5)P2 can be acutely regulated to govern endocytic
rate. The epidermal growth factor (EGF) receptor has been
shown to bind to type IIβ PI(5)P 4-kinase on activation
[42,43], raising the possibility of local increases in PI(4,5)P2
concentration in this case. EGF is known to stimulate endo-
cytic rate; however, this has been attributed to activation of
the Rab5 GTPase [44]. More definite evidence comes from
recent studies of endocytosis in synaptic terminals. Here,
postsynaptic activity was shown to stimulate PI(4,5)P2 pro-
duction on internalising endosomes at the presynaptic ter-
minus through a nitric oxide dependent pathway [45]. In
this case at least, it would seem that PI(4,5)P2 levels can be
used to control the rate of internalisation.
The subsequent steps of endocytosis also require PI(4,5)P2:
invagination of the plasma membrane to form a clathrin-
coated pit is driven by recruitment of the AP-2 adaptor [33].
This heterotrimeric protein binds to the clathrin lattice
through its β2-subunit and to PI(4,5)P2 through an amino-
terminal basic motif in its α-subunit [46]. In addition to con-
tributing to the conformation of the clathrin-coated pit,
AP-2 also binds to the tyrosine-based internalisation motif
of certain receptors through its µ-subunit [47]. Following
invagination, constriction and ligation of the neck of the
coated pit occurs to generate an internalised coated vesicle.
This process is mediated through recruitment of the
GTPase dynamin which makes a number of interactions
including direct contact with the membrane through its
PI(4,5)P2-binding PH domain [48,49].
During the final stage of endocytosis, the internalised
vesicle looses its clathrin coat, producing a nascent early
endosome. The uncoating reaction depends on the actions
of synaptojanin-1, a phosphatidylinositide phosphatase that
rapidly terminates the PI(4,5)P2 signal, allowing release of
the PI(4,5)P2-dependent cofactors and so imparting direc-
tionality to the process of internalisation [50].
A number of other accessory factors with less well-defined
roles are recruited to sites of clathrin-dependent endocytosis
through PI(4,5)P2-binding modules [32]. One intriguing
example is the Huntingtin interacting-protein related-
protein 1 (HipR1). HipR1 contains an amino-terminal
ENTH domain and is tightly localised to clathrin-coated
vesicles [51]. It also contains a carboxy-terminal actin-
binding module, bringing us to the question of the func-
tion of actin in endocytosis. 
Phosphoinositides play a fundamental role in regulating
the actin cytoskeleton [52] and it would seem likely that
the clustering of PI(4,5)P2 during endocytosis would affect
the local cytoskeletal framework. The actin cytoskeleton is
required for several endocytic steps in yeast [53], and dele-
tion of the yeast homologue of HipR1, Sla2p, causes endo-
cytic defects [54]. In higher eukaryotes, the function of
actin in endocytosis is less clear, however several proteins
involved in endocytosis bind to F-actin directly, such as
HipR1, or indirectly, such as dynamin [55]. One hypothe-
sis is that local reorganisation of the cortical actin cytoskele-
ton, a mesh of polymerised actin lying directly under the
plasma membrane, may be required to allow passage of the
budding pit [55]. Certainly, the area directly surrounding
clathrin-coated pits is depleted of polymerised actin [56].
The actin cytoskeleton may also be involved in the spatial
restriction of endocytosis. At neuromuscular junctions, a
clearly visible barrier of polymerised actin defines highly
concentrated sites of endocytosis adjacent to sites of neu-
rotransmitter release [55]. These synaptic structures repre-
sent a specialised and highly efficient form of endocytosis,
however, studies with actin depolymerising agents suggest
that the actin cytoskeleton has a general role in maintain-
ing restricted sites for endocytosis [56].
Perhaps the most surprising role for actin in endocytic
traffic comes with the recent discovery of vesicle propul-
sion within the cell by short-lived ‘comet tails’ of poly-
merised actin [57]. This is a PI(4,5)P2-dependent event
that can be driven by overexpression of type I PI(4)P
5-kinase [58]. The function of the PI(4,5)P2 is almost cer-
tainly to recruit and activate members of the Wiskott-
Aldrich Syndrome protein (WASP) family, which in turn
recruit and activate the actin branching complex Arp2/3 [58].
Despite the concentration of PI(4,5)P2 in clathrin-coated
vesicles, analysis of the identities of the vesicles propelled
by actin comets suggests that this process has greater rele-
vance to internalisation of cargo through clathrin-indepen-
dent or macropinocytic routes [58]. It is possible that the
clathrin-coat excludes assembly of polymerised actin,
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either physically or through sequestration of the PI(4,5)P2
head groups. Certainly, later uncoated endosomal pathway
components, such as multivesicular endosomes and lyso-
somes are capable of forming actin comets [59]. It has
been proposed that these short-lived actin tails allow vesi-
cles to explore their local environment and locate micro-
tubule tracks. It is tempting to speculate that the extremely
transitory nature of these structures is linked to rapid
turnover of phosphoinositides on the vesicle surface and it
will be interesting to test this hypothesis using GFP-
linked biosensors. 
Phosphatidylinositol 3-monophosphate in
endosomal sorting — the role of FYVE domains
After internalisation, cell surface molecules, including
receptors, are delivered to the peripheral early endosomes
[60]. Early endosomes fuse not only with incoming vesi-
cles from the surface, but also undergo homotypic fusion,
resulting in a highly dynamic structure. Proteins in the
early endosome are sorted for delivery to one of at least
three endosomal destinations: the surface for rapid recy-
cling; the lysosome via the late endosome; or the perinu-
clear recycling endosome (Figure 4). 
A direct role for phosphoinositides in endosomal traffick-
ing was originally demonstrated by genetic studies of
protein transport to the yeast vacuole, the equivalent of
the mammalian lysosome. More than forty vacuolar protein-
sorting (VPS) genes are required for transport from the
Golgi apparatus to the vacuole. One of these genes, VPS34,
was found to encode a phosphoinositide 3-kinase that
specifically phosphorylates phosphatidylinositol to produce
phosphatidylinositol 3-monophosphate (PI(3)P) [61]. Tem-
perature-sensitive vps34 mutant cells exhibit an immedi-
ate defect in protein sorting to the vacuole strongly
supporting a role for the Vps34 PI 3-kinase in vesicular
transport from the Golgi to the vacuole [61]. 
How does PI(3)P regulate vesicle-mediated protein trans-
port? Recent work has identified a set of effector mole-
cules that bind directly to this lipid. One of these, the
human early endosomal antigen (EEA1) protein, is a
peripheral membrane protein that interacts with the active
form of the Rab5 GTPase [62]. EEA1 must associate with
membranes in order to stimulate homo- and heterotypic
early endosome fusion — an interaction which requires
the presence on the membrane of PI(3)P, active Rab5, and
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Figure 4
Localization of phosphoinositides in
membrane trafficking pathways. Work using
GFP-based biosensors has revealed discrete
localizations of phosphoinositides at sites of
membrane traffic. PI(4,5)P2 is seen to mark
sites of membrane budding and fusion in
processes like endocytosis and phagocytosis.
PI(3)P marks early endosomes (EE) and
internal structures in late multivesicular
endosomes (MVB). The esoteric lipid
PI(3,5)P2 plays a role in sorting into these late
endosomal structures. This snapshot of
phosphoinositide localization illustrates their
cellular function as markers of membrane
events. This is only half of the story — the
interconversions between phosphoinositides
in membrane traffic are highly dynamic and
impart processivity to trafficking pathways
(see text for more details).
Phagocytosis
Pinocytosis
Endocytosis
EE
MVB
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the FYVE domain of EEA1. Several groups have now
shown that for EEA1 and other FYVE domain containing
proteins such as Hrs-1, Vps27p, Vac1p, Fab1p, and Pib1p,
the FYVE domain can directly and selectively bind PI(3)P.
This interaction has been shown to target these proteins
to endosomes in vivo [36,63,64] (Figure 2). Thus, the
FYVE domain represents a conserved adaptor domain
whose primary function is to act as a membrane-attach-
ment module that depends upon interaction with PI(3)P.
High affinity binding of FYVE domains to PI(3)P seems to
depend on the intact lipid and its presence within a mem-
brane structure. This is in contrast to phosphoinositide-
binding to the PH domains from PLC-δ1, Grp1 and Btk,
which are almost exclusively driven through interactions
with the inositol phosphate head group.
Following nuclear magnetic resonance (NMR) studies of
the EEA1 FYVE domain in complex with di-C4-PI(3)P, as
well as observations of its interaction with PI(3)P-contain-
ing mixed micelles, Kutateladze and Overduin [65] have
suggested a three-step mechanism for the interaction of the
FYVE domain with the PI(3)P-containing membrane. An
exposed hydrophobic loop formed from residues immedi-
ately preceding the FYVE signature motif — a region well
conserved among FYVE domains — initially contacts the
membrane in a non-specific manner. This causes a small
conformational change opening up the basic PI(3)P-
binding pocket, which then binds to the head group of
PI(3)P [65]. This study argues that polar interactions with
the PI(3)P head group and hydrophobic interactions with
the membrane interior cooperate to drive high-affinity
binding of the FYVE domain to PI(3)P-containing mem-
branes. Thus, the ability of FYVE domains to penetrate the
membrane surface is likely to explain the difference
between FYVE and PH domains in the extent to which the
inositol phosphate head group drives membrane binding.
Given the specificity of the FYVE domain for PI(3)P
[63,64] a number of groups have tried to use this domain as
a probe to visualise the intracellular localisation of PI(3)P.
However, in the absence of the adjacent Rab5 binding
domain, the EEA1 FYVE domain is cytosolic, indicating
that it binds with too low an affinity for PI(3)P to be a
useful probe [66,67]. This problem has been overcome by
the use of a tandem FYVE domain of the hepatocyte
growth factor-regulated tyrosine kinase substrate, Hrs.
When expressed in mammalian cells, this probe revealed
that PI(3)P is undetectable in most intracellular mem-
branes of fibroblasts, including the Golgi and the plasma
membrane [68]. However, PI(3)P is abundant on the limit-
ing membranes of early endosomes, and on the membranes
of intralumenal vesicles of multivesicular endosomes [68]. 
Over 30 different proteins have now been identified that
contain a FYVE domain [63]. Rabenosyn-5 is a newly
identified FYVE domain containing protein which, like
EEA1, is required for homo- and heterotypic early endo-
some fusion and binds Rab5-GTP and PI(3)P [69].
Another recently identified FYVE domain protein,
Rabip4, binds specifically to Rab4–GTP and is localised to
the early endosomes [70]. Whereas Rabenosyn-5 appears
to regulate transport of lysosomal enzymes from the trans
Golgi network (TGN) to the endocytic pathway, Rabip4
appears to be involved in the control of recycling from
early endosomes [70]. Thus, at least with these cases and
with EEA1, the FYVE domain binding to PI(3)P coupled
with the all important interaction with distinct Rab pro-
teins can induce a certain degree of directionality in endo-
cytic membrane traffic.
Other FYVE domain-containing proteins include enzymes
that metabolise PI(3)P such as the phosphatidylinositol
3-phosphatase FYVE-dual specificity phosphatase 1
(FYVE-DSP1) [71] and the mammalian orthologue of the
yeast PI(3)P 5-kinase Fab1, PIKfyve [72]. This kinase
phosphorylates PI(3)P into phosphatidylinositol 3,5-bis-
phosphate (PI(3,5)P2) and has been localised to multi-
vesicular bodies indicating a role for PI(3,5)P2 in the late
endocytic pathway. This is in line with previous data
showing that mutations in Fab1 result in an expanded
vacuole [73]. At present however, our understanding of
this lipid is hampered by the lack of identified PI(3,5)P2
effectors. One approach to addressing this issue may be
through examining whether specific PI(3,5)P2-binding
PH, FYVE or PX domains (see below) can be identified.
Irrespective of this, it is clear that regulation of the levels
of 3-phosphoinositides is vitally important for proper endo-
cytic membrane trafficking. 
PX domains: the new kids on the block
Such a conclusion has been reinforced following the recent
demonstration that PX domains function as phosphoinosi-
tide-directed membrane targeting motifs [74–79], (reviewed
in [80,81]; Figure 2). The PX domain was initially identi-
fied as a conserved motif of approximately 130 residues
within the p40phox and p47phox subunits of the neutrophil
NADPH oxidase superoxide-generating complex [82]. PX
domains can be found in a wide variety of proteins
involved in cell signalling (phospholipase D1 and D2,
class II PI 3-kinases), vesicle trafficking (human sorting
nexins, yeast Vam7p), and control of yeast bud emergence
and polarity (Bem1p and Bem3p). Currently, at least 57
human and 15 yeast proteins that contain PX domains
have been identified [80,81].
Vam7p is an essential component of vacuolar sorting
in yeast helping to transport cargo such as hydrolytic
enzymes to the vacuole [83]. Vam7p is a soluble N-ethyl-
maleimide-sensitive factor (NSF) attachment protein
receptor (t-SNARE) that contains an amino-terminal PX
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domain. It is targeted to vacuoles, where it acts as a
SNAP-25 homolog in the docking and fusion of transport
intermediates with the vacuole [84]. Recently, it has
been shown that the Vam7p membrane association
requires a functional PX domain and PI(3)P generation in
vivo, and that the Vam7p PX domain binds to PI(3)P
in vitro [74]. Thus the PX domain is likely to concentrate
Vam7p at its site of action through an inherent ability to
bind PI(3)P.
Further evidence for the role of the PX domain as a PI(3)P
directed membrane-targeting module has been provided
by the analysis of the human sorting nexin, SNX3 [77].
Sorting nexins are an emerging family of widely expressed
proteins believed to be part of the complex molecular
machinery required for protein trafficking — currently
more than 16 SNXs have been identified [84–87].
Although the precise functions of these proteins are
unclear, sorting nexins appear to target cargo proteins such
as growth factor receptors to specific organelles for post-
translational modification, degradation or recycling. Thus,
overexpression of SNX1 — initially identified through its
ability to bind the cytosolic domain of the EGF receptor
[88] — selectively decreases the amount of EGF receptor
on the cell surface by enhancing the rate of constitutive
and ligand-induced EGF receptor degradation.
As with Vam7p, the PX domain of SNX3 specifically
binds PI(3)P, an interaction that targets this protein to
early and recycling endosomal compartments [77]. In
A431 cells, overexpression of SNX3 shifts the steady-
state distribution of transferrin receptor (TfR) from the
surface to a SNX3-positive tubular-vesicular structure. More
detailed analysis has revealed that proteins of the early
endosome (EEA1), the recycling endosome (TfR), and
the late endosome (mannose-6-phosphate receptor and
syntaxin) are all present in this structure. This protein dis-
tribution indicates that SNX3 overexpression induces a
mixing of the early, recycling and late endosomal compart-
ments. Overexpression of SNX3 mutants defective in
PI(3)P-binding, showed they were cytosolic and the surface
level of TfR remained unaltered, strongly suggesting that
the PI(3)P-binding activity of SNX3 is necessary for its
endosomal association, which in turn enables SNX3 to
regulate the structure and function of the endosomal
pathway. Further work will be required to elucidate the
molecular basis for the SNX3 induced expansion of
tubular-vesicular structures.
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Figure 5
Phosphoinositide turnover during
phagocytosis. (a) Interaction of the particle
with cell surface receptors causes recruitment
and activation of PI 3-kinaseγ and a rapid local
production of PIP3 on the phagocytic cup. The
action of the SHIP phosphatase leads to a
concomitant local increase in PI(3,4)P2. Type
II PI(4)P 5-kinase is also recruited, causing
PI(4,5)P2 levels to rise. (b) On closure of the
phagocytic cup, the PIP3 levels fall rapidly, as
does the level of PI(4,5)P2.
(c) PI(3)P-containing early endosomes fuse
with the vacuole causing a further elevation of
PI(3)P. The NADPH oxidase complex is now
bound to PI(3)P through the PX domain of its
p40phox subunit and to PI(3,4)P2 through the
PX domain of its p47phox subunit. These
subunits interact with the constitutively
membrane-associated cytochrome b558
forming a fully active complex that directs toxic
superoxide production into the phagocytic
vacuole.
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The identification of the PX domain as a phosphoinositide-
binding module provides significant insight into the func-
tion of this domain in targeting its host protein to specific
cellular membranes. However, ascribing such a function to
the PX domain raises a number of interesting questions
about specificity and regulation. For example, as the PX
motif is found in a wide variety of proteins, it is interesting
to consider whether individual PX domains are capable of
specifically recognising phosphoinositides other than PI(3)P
— an important issue which will likely affect the subcellular
targeting of the host protein (see below). In Saccharomyces
cerevisiae this does not appear to be the case [89].
PX domains and phagocytosis
Phagocytic cells such as neutrophils and macrophages
engulf and destroy invading microorganisms through a
receptor-mediated mechanism that involves extensive
cytoskeletal rearrangements and membrane remodelling
[90]. Receptors on the phagocyte surface that recognise
surrounding components of the microorganism, or opsonins
attached to it, cluster in the area of contact between the
pathogen and phagocyte. Such clustering triggers localised
actin assembly and the formation of a phagosomal cup [90]
(see Figure 5). Following closure of the cup, activation
of the multi-subunit phagocyte oxidase (Phox) complex
on the phagosomal membrane kills the invading microor-
ganism with a cocktail of reactive oxygen species [90].
As mentioned above, prominent among the signals regu-
lating phagocytosis are rapid changes in phosphoinositide
metabolism [12,91]. 
There is strong evidence that localised accumulation of
PIP3 around the phagocytic cup, through activation of
class I PI 3-kinases [91], regulates phagosome closure, pos-
sibly through small GTPases of the Rho and ARF family
[90]. More recently, Ellson and co-workers [92,93] have
shown that when a macrophage cell line expressing a GFP
probe specific for PI(3)P is challenged with IgG-opsonised
zymosan particles, there is a dramatic accumulation of the
probe on the phagosomal membrane following phagosomal
closure, consistent with PI(3)P being rapidly synthesised
on phagosomal membranes. Such a dramatic accumulation
of PI(3)P around the entire phagosome suggests that
PI(3)P is clearly an ideal candidate for controlling the early
stages of phagosomal maturation.
How such a rise in PI(3)P is achieved is currently unclear.
One possibility is that PI(3)P is produced by the sequen-
tial breakdown of PIP3 and phosphatidylinositol 3,4-bispho-
sphate (PI(3,4)P2) by a 5- and 4-phosphatase, respectively.
This is consistent with the production of PIP3 prior to
phagosomal closure [91] and the recruitment of the PIP3
5-phosphatase (SHIP) to phagosomal membranes [94].
The other two possible routes for PI(3)P production are
through direct phosphorylation of phosphatidylinositol by
either class II or class III PI 3-kinases on the phagosomal
membrane. In this context it is interesting that following
phagosome closure, Ellson et al. [92] observed the docking
and fusion of early endosomes with the nascent phago-
some. This occurred prior to the large global increases in
phagosomal PI(3)P levels and may represent a mechanism
for delivery of an active PI 3-kinase to the phagosomal
membrane. Furthermore, Vieira et al. [95] have now con-
firmed the presence of class I PI 3-kinase activity in the
nascent phagosomal cup and have shown that the class III
PI 3-kinase Vps34 is responsible for PI(3)P synthesis on
phagosomal membranes. The latter process is essential for
phagosome maturation.
What is the relevance of such dynamic changes in PI(3)P
for phagocytic function? Recent studies [75,76] have
shown that two components of the phagocytic oxidase
complex, p40phox and p47phox, contain PX domains that
specifically bind PI(3)P and PI(3,4)P2, respectively. This
raises the possibility that the elevation in PI(3)P — and
perhaps PI(3,4)P2 — may be the signal that recruits these
proteins to the phagosome. The PI(3)P driven assembly of
p47phox, p40phox and the associated p67phox with the con-
stitutively membrane-bound components of the oxidase
complex would result in a functional oxidase capable of
producing the toxic oxygen metabolites needed to kill the
invading microorganisms. The importance of this interac-
tion is highlighted by the observation that one of the
mutations associated with patients suffering from chronic
granulomatous disease (these patients have a strong sus-
ceptibility to bacterial and fungal infections) is found in
the PX domain of p47phox; this mutation abolishes its
binding to PI(3,4)P2 [75].
Intriguingly, PI(3)P has also been seen to accumulate on
the membranes of another specialised endocytic structure.
When Salmonella invade cells they become enclosed in a
membrane-bound compartment termed a Salmonella con-
taining vacuole. This compartment appears to share some
features with early endosomes, but provides a privileged
environment in which the bacteria can divide rather than
be delivered to late endosomes and lysosomes [96]. The
use of another FYVE domain GFP probe has shown that
PI(3)P accumulates in both the cell surface ruffles that
emerge upon Salmonella binding and in the membranes of
the vacuoles [97]. Given that there is a rapid accumulation
of PI(3)P on phagosome membranes, this accumulation on
Salmonella containing vacuole membranes may reflect a
cellular response to the invading bacteria.
It is of note that the accumulation of PI(3)P on Salmonella
containing vacuoles occurs even in the presence of the PI
3-kinase inhibitor wortmannin, showing that a wortmannin
resistant PI 3-kinase is involved in the process [97]. Fur-
thermore, binding of the FYVE–GFP probe to Salmonella
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containing vacuoles was periodic: the vacuoles appeared to
‘flash’ as they gained and lost the GFP probe. These data
suggest that the levels of PI(3)P on the vacuole mem-
branes fluctuate. It is possible that this represents a ‘battle’
between the invading bacteria manipulating the composi-
tion of the vacuole to lower PI(3)P levels and the host cell
trying to maintain high levels of PI(3)P on the membranes
and thus target the bacterium for destruction. Destruction
occurs either by recruitment of the phagocytic oxidase
system or delivery of the vacuole to later points along the
endocytic pathway.
The above data show that just as pathogenic mycobacteria
appear to be able to arrest phagosome maturation by reduc-
ing available PI(3)P in the phagosome membrane [98],
Salmonella apparently do a similar thing in bacterium-con-
taining vacuole membranes. The fact that, as a means of
evading host cell defences, both of these pathogens target
PI(3)P levels in the host cell membranes that envelop
them underlines the importance of this phosphoinositide,
and the proteins that interact with it, in the pathways from
the cell surface to various endosome destinations.
Conclusions
An emerging and in some cases well developed theme in
phosphoinositide signalling is their role as dynamic scaf-
folds for the regulated formation of membrane associated
signalling complexes. The more historical concept of ‘rigid’
signalling envisages receptors and other signalling proteins
being quite fixed, and spatial signal transmission proceed-
ing via the rapid diffusion of second messengers.  In con-
trast, signalling through phosphoinositides is a highly
dynamic process that is principally reliant upon networks
of low affinity interactions; it is therefore amenable to both
rapid and subtle manipulation. A key aspect of the signal
transmission process is signalling proteins that undergo
substantial translocation and reversible binding interac-
tions. These signalling proteins move to and act at defined
locations specified by the local phosphoinositide environ-
ment — arguably a more ‘soft’ form of signalling. 
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